Faculty
Camille Abboud.jpg

Camille N. Abboud, MD

Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia

Clinical Interests

  • Acute & chronic leukemia
  • Myelodysplastic syndrome
  • Myeloproliferative disorders
  • Lymphoma
  • Myeloma

Contact

  • 314-747-8439 (tel)
  • 314-454-7551 (fax)
  • 11th Floor Mid-Campus Center (office)
  • Division of Oncology
    Campus Box 8007
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110

Original Articles

  • Patterns of Infectious Complications in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Treated With 10-Day Decitabine Regimen
    Ali AM, Weisel D, Gao F, Uy GL, Cashen AF, Jacoby MA, Wartman LD, Ghobadi A, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Schroeder MA, Westervelt P, DiPersio JF, Welch JS
    Cancer Med 2017 Oct 23; [Epub ahead of print]
  • Lack of Prognostic Impact of MyD88 L265P Mutation for DLBCL Patients Undergoing Autologous Stem Cell Transplantation
    Lee YS, Liu J, Fricano KA, Webb EM, Toolsie DR, Jones S, Rhoads JA, Vij R, Cashen AF, Abboud CN, Westervelt P, Bartlett NL, DiPersio JF, Kreisel FH, Lim KH
    Biol Blood Marrow Transplant 2017 Aug 25; [Epub ahead of print]
  • Results of Prospective Randomized, Open Label, Non-Inferiority Study of Tbo-Filgrastim (Granix(R)) Versus Filgrastim (Neupogen(R)) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
    Bhamidipati PK, Fiala MA, Grossman BJ, DiPersio JF, Stockerl-GoldsteinK, Gao F, Uy GL, Westervelt P, Schroeder MA, Cashen AF, Abboud CN, Vij R
    Biol Blood Marrow Transplant 2017 Aug 7; [Epub ahead of print]
  • Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony-Stimulating Factor in Lymphoma Patients Undergoing Autologous Stem Cell Collection
    Cashen AF, Rettig M, Gao F, Smith A, Abboud C, Stockerl-Goldstein K, Vij R, Uy G, Westervelt P, DiPersio J
    Biol Blood Marrow Transplant 2017 Aug;23(8):1282-1289
  • Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
    O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Bhatt V, Bixby D, Blum W, Coutre SE, De Lima M, Fathi AT, Fiorella M, Foran JM, Gore SD, Hall AC, Kropf P, Lancet J, Maness LJ, Marcucci G, Martin MG, Moore JO, Olin R, Peker D, Pollyea DA, Pratz K, Ravandi F, Shami PJ, Stone RM, Strickland SA, Wang ES, Wieduwilt M, Gregory K, Ogba N
    J Natl Compr Canc Netw 2017 Jul;15(7):926-957
  • Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function After Allogeneic Hematopoietic Cell Transplantation
    Ghobadi A, Fiala MA, Ramsingh G, Gao F, Abboud CN, Stockerl-Goldstein K, Uy GL, Grossman BJ, Westervelt P, DiPersio JF
    Biol Blood Marrow Transplant 2017 Jul;23(7):1072-1077
  • Mobilization of Allogeneic Peripheral Blood Stem Cell Donors With Intravenous Plerixafor Mobilizes a Unique Graft
    Schroeder MA, Rettig MP, Lopez S, Christ S, Fiala M, Eades W, Mir FA, Shao J, McFarland K, Trinkaus K, Shannon W, Deych E, Yu J, Vij R, Stockerl-Goldstein K, Cashen AF, Uy GL, Abboud CN, Westervelt P, DiPersio JF
    Blood 2017 May 11;129(19):2680-2692
  • Single Institution Experience With G-CSF Mobilized T-Cell Replete Haploidentical Hematopoietic Cell Transplantation
    Huselton E, Slade M, DiPersio JF, Westervelt P, Vij R, Uy GL, Fehniger TA, Abboud CN, Gao F, Schroeder MA, Romee R
    Bone Marrow Transplant 2017 May;52(5):769-771
  • Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy
    Uy GL, Duncavage EJ, Chang GS, Jacoby MA, Miller CA, Shao J, Heath S, Elliott K, Reineck T, Fulton RS, Fronick CC, O'Laughlin M, Ganel L, Abboud CN, Cashen AF, DiPersio JF, Wilson RK, Link DC, Welch JS, Ley TJ, Graubert TA, Westervelt P, Walter MJ
    Leukemia 2017 Apr;31(4):872-881
  • T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation From Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia
    How J, Slade M, Vu K, DiPersio JF, Westervelt P, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Romee R
    Biol Blood Marrow Transplant 2017 Apr;23(4):648-653
  • A Phase 1/2 Study of Chemosensitization With Plerixafor Plus G-CSF in Relapsed or Refractory Acute Myeloid Leukemia
    Uy GL, Rettig MP, Stone RM, Konopleva MY, Andreeff M, McFarland K, Shannon W, Fletcher TR, Reineck T, Eades W, Stockerl-Goldstein K, Abboud CN, Jacoby MA, Westervelt P, DiPersio JF
    Blood Cancer J 2017 Mar 10;7(3):e542
  • TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Welch JS, Petti AA, Miller CA, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Baty JD, Duncavage EJ, Tandon B, Lee YS, Wartman LD, Uy GL, Ghobadi A, Tomasson MH, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Cashen AF, Schroeder MA, Jacoby MA, Heath SE, Luber K, Janke MR, Hantel A, Khan N, Sukhanova MJ, Knoebel RW, Stock W, Graubert TA, Walter MJ, Westervelt P, Link DC, DiPersio JF, Ley TJ
    N Engl J Med 2016 Nov 24;375(21):2023-2036
  • NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017
    Pallera A, Altman JK, Berman E, Abboud CN, Bhatnagar B, Curtin P, DeAngelo DJ, Gotlib J, Hagelstrom RT, Hobbs G, Jagasia M, Kantarjian HM, Kropf P, Metheny L, Moore JO, Ontiveros E, Purev E, Quiery A, Reddy VV, Rose MG, Shah NP, Smith BD, Snyder DS, Sweet KL, Tibes R, Yang DT, Gregory K, Sundar H, Deininger M, Radich JP
    J Natl Compr Canc Netw 2016 Dec;14(12):1505-1512
  • Phase II Study of Propylene Glycol-Free Melphalan Combined With Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
    Cashen AF, Fletcher T, Ceriotti C, Gao F, Ghobadi A, Vij R, Stockerl-Goldstein K, DiPersio J, Abboud C
    Biol Blood Marrow Transplant 2016 Dec;22(12):2155-2158
  • Cytomegalovirus Viremia, Disease, and Impact on Relapse in T-Cell Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide
    Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Lawrence SJ, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Dubberke ER, Trinkaus K, Romee R
    Haematologica 2016 Nov;101(11):e465-e468
  • Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
    Ghobadi A, Choi J, Fiala MA, Fletcher T, Liu J, Eissenberg LG, Abboud C, Cashen A, Vij R, Schroeder MA, Pusic I, Stockerl-Goldstein K, Jacoby M, Uy G, DiPersio J, Westervelt P
    Leuk Res 2016 Oct;49:1-6
  • Severe Cytokine-Release Syndrome After T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated With Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated
    Abboud R, Keller J, Slade M, DiPersio JF, Westervelt P, Rettig MP, Meier S, Fehniger TA, Abboud CN, Uy GL, Vij R, Trinkaus KM, Schroeder MA, Romee R
    Biol Blood Marrow Transplant 2016 Oct;22(10):1851-60
  • Do Adults Aged 70 Years or Older With Acute Myeloid Leukemia Benefit From Allogeneic Hematopoietic Cell Transplantation?
    Rashidi A, DiPersio JF, Westervelt P, Vij R, Abboud CN, Romee R
    Leukemia 2016 Aug;30(8):1797-9
  • HLA Disparity Is Not Inconsequential in Peripheral Blood T-Replete Haploidentical Hematopoietic Stem Cell Transplantation
    Rashidi A, DiPersio JF, Westervelt P, Abboud CN, Schroeder MA, Pusic I, Cashen AF, Fehniger TA, Romee R
    Bone Marrow Transplant 2016 Sep;51(9):1275-8
  • Chemotherapy Versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Stem Cell Transplant
    Motabi IH, Ghobadi A, Liu J, Schroeder M, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Uy GL, Vij R, Westervelt P, DiPersio JF
    Biol Blood Marrow Transplant 2016 Jul;22(7):1324-9
  • Leukostasis in Adult Acute Hyperleukocytic Leukemia: A Clinician's Digest
    Ali AM, Mirrakhimov AE, Abboud CN, Cashen AF
    Hematol Oncol 2016 Jun;34(2):69-78
  • Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-Versus-Host Disease After Mucotoxic Myeloablative Conditioning
    Rashidi A, DiPersio JF, Westervelt P, Abboud CN, Schroeder MA, Cashen AF, Pusic I, Romee R
    Biol Blood Marrow Transplant 2016 Jun;22(6):1137-41
  • Acute Myeloid Leukemia Presenting With Extensive Bone Marrow Necrosis, Leukemia Cutis and Testicular Involvement: Successful Treatment With Allogeneic Hematopoietic Stem Cell Transplantation
    Rashidi A, DiPersio JF, Westervelt P, Abboud CN, Romee R
    Bone Marrow Transplant 2016 Mar;51(3):454-5
  • Safety and Tolerability of Eltrombopag Versus Placebo for Treatment of Thrombocytopenia in Patients With Advanced Myelodysplastic Syndromes or Acute Myeloid Leukaemia: A Multicentre, Randomised, Placebo-Controlled, Double-Blind, Phase 1/2 Trial
    Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Gotze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A
    Lancet Haematol 2015 Oct;2(10):e417-26
  • Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F
    Stein BL, Oh ST, Berenzon D, Hobbs GS, Kremyanskaya M, Rampal RK, Abboud CN, Adler K, Heaney ML, Jabbour EJ, Komrokji RS, Moliterno AR, Ritchie EK, Rice L, Mascarenhas J, Hoffman R
    J Clin Oncol 2015 Nov 20;33(33):3953-60
  • Maintenance Therapy With Decitabine After Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
    Pusic I, Choi J, Fiala MA, Gao F, Holt M, Cashen AF, Vij R, Abboud CN, Stockerl-Goldstein KE, Jacoby MA, Uy GL, Westervelt P, DiPersio JF
    Biol Blood Marrow Transplant 2015 Oct;21(10):1761-9
  • Hematologic Recovery After Pretransplant Chemotherapy Does Not Influence Survival After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients
    Vu K, Manjappa S, DiPersio JF, Gao F, Westervelt P, Vij R, Stockerl-Goldstein KE, Uy GL, Abboud CN, Schroeder MA, Fehniger TA, Cashen AF, Romee R
    Biol Blood Marrow Transplant 2015 Aug;21(8):1425-30
  • Granulocyte Colony-Stimulating Factor Priming Improves Haploidentical Stem Cell Transplantation in High-Risk Acute Myeloid Leukemia Subsets: A New Role for an Old Work Horse
    Abboud CN
    Biol Blood Marrow Transplant 2014 Dec;20(12):1873-4
  • Chronic Myelogenous Leukemia, Version 1.2015
    O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, Curtin P, DeAngelo DJ, Deininger M, Devine S, Fathi AT, Gotlib J, Jagasia M, Kropf P, Moore JO, Pallera A, Reddy VV, Shah NP, Smith BD, Snyder DS, Wetzler M, Gregory K, Sundar H
    J Natl Compr Canc Netw 2014 Nov;12(11):1590-610
  • A Phase II Study of V-BEAM as Conditioning Regimen Before Second Auto-SCT for Multiple Myeloma
    Wang TF, Fiala MA, Cashen AF, Uy GL, Abboud CN, Fletcher T, Wu N, Westervelt P, DiPersio JF, Stockerl-Goldstein KE, Vij R
    Bone Marrow Transplant 2014 Nov;49(11):1366-70
  • Haploidentical Transplantation Using G-CSF-Mobilized T-Cell Replete PBSCs and Post-Transplantation CY After Non-Myeloablative Conditioning Is Safe and Is Associated With Favorable Outcomes
    Bhamidipati PK, DiPersio JF, Stockerl-Goldstein K, Rashidi A, Gao F, Uy GL, Westervelt P, Vij R, Schroeder MA, Abboud CN, Keller JW, Fehniger TA, Romee R
    Bone Marrow Transplant 2014 Aug;49(8):1124-6
  • A Phase I Dose Escalation Study of Oral Bexarotene in Combination With Intravenous Decitabine in Patients With AML
    Welch JS, Niu H, Uy GL, Westervelt P, Abboud CN, Vij R, Stockerl-Goldstein KE, Jacoby M, Pusic I, Schroeder MA, DiPersio JF, Cashen AF
    Am J Hematol 2014 Aug;89(8):E103-8
  • Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older With Acute Myeloid Leukemia
    Jacoby MA, Martin MG, Uy GL, Westervelt P, DiPersio JF, Cashen A, Stockerl-Goldstein K, Vij R, Luo J, Reineck T, Bernabe N, Abboud CN
    Am J Hematol 2014 May;89(5):487-92
  • Phase I Study of Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor (CLAG Regimen) and Midostaurin and All-Trans Retinoic Acid in Relapsed/Refractory AML
    Ramsingh G, Westervelt P, McBride A, Stockerl-Goldstein K, Vij R, Fiala M, Uy G, Cashen A, DiPersio JF, Abboud CN
    Int J Hematol 2014 Mar;99(3):272-8
  • Protective Effect of Cytomegalovirus Reactivation on Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Conditioning Regimen
    Manjappa S, Bhamidipati PK, Stokerl-Goldstein KE, DiPersio JF, Uy GL, Westervelt P, Liu J, Schroeder MA, Vij R, Abboud CN, Fehniger TA, Cashen AF, Pusic I, Jacoby M, Meera SJ, Romee R
    Biol Blood Marrow Transplant 2014 Jan;20(1):46-52
  • Chronic Myelogenous Leukemia, Version 1.2014
    O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, DeAngelo DJ, Deininger M, Devine S, Fathi AT, Gotlib J, Jagasia M, Kropf P, Moore JO, Pallera A, Pinilla-Ibarz J, Reddy VV, Shah NP, Smith BD, Snyder DS, Wetzler M, Gregory K, Sundar H
    J Natl Compr Canc Netw 2013 Nov;11(11):1327-40
  • Acute Myeloid Leukemia, Version 2.2013
    O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Lancet J, Maness LJ, Marcucci G, Martin MG, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Wang ES, Gregory KM, Naganuma M
    J Natl Compr Canc Netw 2013 Sep 1;11(9):1047-55
  • The Price of Drugs for Chronic Myeloid Leukemia (CML) Is a Reflection of the Unsustainable Prices of Cancer Drugs: From the Perspective of a Large Group of CML Experts
    Experts in Chronic Myeloid Leukemia (Authors include: Abboud CN)
    Blood 2013 May 30;121(22):4439-42
  • A Phase 1 Study of Concomitant High-Dose Lenalidomide and 5-Azacitidine Induction in the Treatment of AML
    Ramsingh G, Westervelt P, Cashen AF, Uy GL, Stockerl-Goldstein K, Abboud CN, Bernabe N, Monahan R, DiPersio JF, Vij R
    Leukemia 2013 Mar;27(3):725-8
  • Acute Myeloid Leukemia
    O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Goorha S, Lancet J, Maness LJ, Marcucci G, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Tallman MS, Wang ES, Naganuma M, Gregory KM
    J Natl Compr Canc Netw 2012 Aug;10(8):984-1021
  • Allogeneic HSCT for ATL: A Good Start
    Abboud C
    Blood 2012 Aug 23;120(8):1541-2
  • A Phase 1/2 Study of Chemosensitization With the CXCR4 Antagonist Plerixafor in Relapsed or Refractory Acute Myeloid Leukemia
    Uy GL, Rettig MP, Motabi IH, McFarland K, Trinkaus KM, Hladnik LM, Kulkarni S, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Vij R, Westervelt P, DiPersio JF
    Blood 2012 Apr 26;119(17):3917-24
  • Chronic Myelogenous Leukemia
    O'Brien S, Abboud CN, Akhtari M, Altman J, Berman E, DeAngelo DJ, Devine S, Fathi AT, Gotlib J, Jagasia M, Moore JO, Pinilla-Ibarz J, Radich JP, Reddy VV, Shah NP, Shami PJ, Smith BD, Snyder DS, Wetzler M, Yunus F
    J Natl Compr Canc Netw 2012 Jan;10(1):64-110
  • Oral Valganciclovir Versus Ganciclovir as Delayed Pre-Emptive Therapy for Patients After Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Trial (04-0274) and Review of the Literature
    Chawla JS, Ghobadi A, Mosley J 3rd, Verkruyse L, Trinkaus K, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Uy GL, Westervelt P, DiPersio JF, Vij R
    Transpl Infect Dis 2012 Jun;14(3):259-67
  • Combination Decitabine, Arsenic Trioxide, and Ascorbic Acid for the Treatment of Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Phase I Study
    Welch JS, Klco JM, Gao F, Procknow E, Uy GL, Stockerl-Goldstein KE, Abboud CN, Westervelt P, DiPersio JF, Hassan A, Cashen AF, Vij R
    Am J Hematol 2011 Sep;86(9):796-800
  • Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated With Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation
    Smeltzer JP, Cashen AF, Zhang Q, Homb A, Dehdashti F, Abboud CN, DiPersio JF, Stockerl-Goldstein KE, Uy GL, Vij R, Westervelt P, Bartlett NL, Fehniger TA
    Biol Blood Marrow Transplant 2011 Nov;17(11):1646-52
  • Acute Myeloid Leukemia
    O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Coutre SE, Damon LE, Foran JM, Goorha S, Maness LJ, Marcucci G, Maslak P, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Tallman MS, Wang ES
    J Natl Compr Canc Netw 2011 Mar;9(3):280-317
  • A Phase I Trial: Dose Escalation of Melphalan in the "BEAM" Regimen Using Amifostine Cytoprotection
    Phillips GL 2nd, Bernstein SH, Liesveld JL, Abboud CN, Becker MW, Constine LS, Ifthikharuddin JJ, Loughner JE, Milner LA, Vesole DH, Friedberg JW
    Biol Blood Marrow Transplant 2011 Jul;17(7):1033-42
  • A Phase 2 Study of High-Dose Lenalidomide as Initial Therapy for Older Patients With Acute Myeloid Leukemia
    Fehniger TA, Uy GL, Trinkaus K, Nelson AD, Demland J, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Westervelt P, DiPersio JF, Vij R
    Blood 2011 Feb 10;117(6):1828-33
  • Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone--Results of a Multicenter Phase III Study
    Cortes J, Moore JO, Maziarz RT, Wetzler M, Craig M, Matous J, Luger S, Dey BR, Schiller GJ, Pham D, Abboud CN, Krishnamurthy M, Brown A Jr, Laadem A, Seiter K
    J Clin Oncol 2010 Sep 20;28(27):4207-13
  • Salvage Therapy for Acute Myeloid Leukemia With Fludarabine, Cytarabine, and Idarubicin With or Without Gemtuzumab Ozogamicin and With Concurrent or Sequential G-CSF
    Martin MG, Augustin KM, Uy GL, Welch JS, Hladnik L, Goyal S, Tiwari D, Monahan RS, Reichley RM, Cashen AF, Stockerl-Goldstein K, Westervelt P, Abboud CN, DiPersio JF, Vij R
    Am J Hematol 2009 Nov;84(11):733-7
  • Cladribine in the Treatment of Acute Myeloid Leukemia: A Single-Institution Experience
    Martin MG, Welch JS, Augustin K, Hladnik L, DiPersio JF, Abboud CN
    Clin Lymphoma Myeloma 2009 Aug;9(4):298-301
  • A Phase II Study of 5-Day Intravenous Azacitidine in Patients With Myelodysplastic Syndromes
    Martin MG, Walgren RA, Procknow E, Uy GL, Stockerl-Goldstein K, Cashen AF, Westervelt P, Abboud CN, Kreisel F, Augustin K, DiPersio JF, Vij R
    Am J Hematol 2009 Sep;84(9):560-4
  • Allo-SCT Conditioning for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Clofarabine, Cytarabine and ATG
    Martin MG, Uy GL, Procknow E, Stockerl-Goldstein K, Cashen A, Westervelt P, Abboud CN, Augustin K, Luo J, DiPersio JF, Vij R
    Bone Marrow Transplant 2009 Jul;44(1):13-7
  • Another Nail in the AML Coffin
    Abboud CN
    Blood 2009 Jun 11;113(24):6045-6
  • Single-Agent Lenalidomide Induces Complete Remission of Acute Myeloid Leukemia in Patients With Isolated Trisomy 13
    Fehniger TA, Byrd JC, Marcucci G, Abboud CN, Kefauver C, Payton JE, Vij R, Blum W
    Blood 2009 Jan 29;113(5):1002-5
  • Unlocking the Dysplasia Puzzle
    Abboud CN
    Blood 2008 Oct 15;112(8):3005-6
  • Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation
    Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF
    Biol Blood Marrow Transplant 2008 Sep;14(9):1045-56
  • Induction Therapy for Elderly Patients With Acute Myeloid Leukemia
    Martin MG, Abboud CN
    Blood Rev 2008 Nov;22(6):311-20
  • Phase I Study of Cladribine, Cytarabine (Ara-C), Granulocyte Colony Stimulating Factor (G-CSF) (CLAG Regimen) and Simultaneous Escalating Doses of Imatinib Mesylate (Gleevec) in Relapsed/Refractory AML
    Walker AR, Komrokji RS, Ifthikharuddin J, Messina P, Mulford D, Becker M, Friedberg J, Oliva J, Phillips G, Liesveld JL, Abboud C
    Leuk Res 2008 Dec;32(12):1830-6
  • Rapid Method for Detection of Mutations in the Nucleophosmin Gene in Acute Myeloid Leukemia
    Laughlin TS, Becker MW, Liesveld JL, Mulford DA, Abboud CN, Brown P, Rothberg PG
    J Mol Diagn 2008 Jul;10(4):338-45
  • Effects of AMD3100 on Transmigration and Survival of Acute Myelogenous Leukemia Cells
    Liesveld JL, Bechelli J, Rosell K, Lu C, Bridger G, Phillips G 2nd, Abboud CN
    Leuk Res 2007 Nov;31(11):1553-63
  • Apoptosis and Complement-Mediated Lysis of Myeloma Cells by Polyclonal Rabbit Antithymocyte Globulin
    Zand MS, Vo T, Pellegrin T, Felgar R, Liesveld JL, Ifthikharuddin JJ, Abboud CN, Sanz I, Huggins J
    Blood 2006 Apr 1;107(7):2895-903
  • Acute Myelogenous Leukemia--Microenvironment Interactions: Role of Endothelial Cells and Proteasome Inhibition
    Liesveld JL, Rosell KE, Lu C, Bechelli J, Phillips G, Lancet JE, Abboud CN
    Hematology 2005 Dec;10(6):483-94
  • Mini-BEAM and Autologous Hematopoietic Stem-Cell Transplant for Treatment of Post-Transplant Lymphoproliferative Disorders
    Komrokji RS, Oliva JL, Zand M, Felgar R, Abboud CN
    Am J Hematol 2005 Jul;79(3):211-5
  • Phase I Study for Poor-Prognosis Lymphoma: Augmentation of the "BEAM" Regimen With Escalating Dose Melphalan Using Amifostine Cytoprotection and Autologous Hematopoietic Stem Cell Transplantation--A Preliminary Report
    Phillips GL, Abboud CN, Bernstein SH, Friedberg JW, Ifthikharuddin JJ, Lancet JE, Liesveld JL, Spreng E, Johnson V, Chapman M, Vesole DH
    Semin Oncol 2004 Dec;31(6 Suppl 18):59-61
  • Phase I/II Randomized Trial Evaluating the Safety and Clinical Effects of Repifermin Administered to Reduce Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
    Freytes CO, Ratanatharathorn V, Taylor C, Abboud C, Chesser N, Restrepo A, Arango J, Odenheimer D
    Clin Cancer Res 2004 Dec 15;10(24):8318-24
  • Donor Cell Myelodysplastic Syndrome After Allogeneic Stem Cell Transplantation Responding to Donor Lymphocyte Infusion: Case Report and Literature Review
    Komrokji R, Ifthikharuddin JJ, Felgar RE, Abboud CN, Wedow LA, Connaughton A, Bennett JM
    Am J Hematol 2004 Aug;76(4):389-94
  • A Phase 3 Study of Three Induction Regimens and of Priming With GM-CSF in Older Adults With Acute Myeloid Leukemia: A Trial by the Eastern Cooperative Oncology Group
    Rowe JM, Neuberg D, Friedenberg W, Bennett JM, Paietta E, Makary AZ, Liesveld JL, Abboud CN, Dewald G, Hayes FA, Tallman MS, Wiernik PH
    Blood 2004 Jan 15;103(2):479-85
  • Flavonoid Effects on Normal and Leukemic Cells
    Liesveld JL, Abboud CN, Lu C, McNair C, Menon A, Smith A, Rosell K, Rapoport AP
    Leuk Res 2003 Jun;27(6):517-27
  • Effects of the Farnesyl Transferase Inhibitor R115777 on Normal and Leukemic Hematopoiesis
    Liesveld JL, Lancet JE, Rosell KE, Menon A, Lu C, McNair C, Abboud CN, Rosenblatt JD
    Leukemia 2003 Sep;17(9):1806-12
  • The Effects of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-RHuMGDF) on Platelet Recovery in Breast Cancer Patients Undergoing Autologous Bone Marrow Transplantation
    Schuster MW, Beveridge R, Frei-Lahr D, Abboud CN, Cruickshank S, Macri M, Menchaca D, Holden J, Waller EK
    Exp Hematol 2002 Sep;30(9):1044-50
  • Oral Valacyclovir Versus Intravenous Acyclovir in Preventing Herpes Simplex Virus Infections in Autologous Stem Cell Transplant Recipients
    Liesveld JL, Abboud CN, Ifthikharuddin JJ, Lancet JE, Wedow LA, Oliva J, Stamm CG, Nichols D
    Biol Blood Marrow Transplant 2002;8(12):662-5
  • Impact of Mobilized Blood Progenitor Cell Quality Determined by the CFU-GM/CD34+ Ratio on Rapid Engraftment After Blood Stem Cell Transplantation
    Fu SQ, Abboud CN, Brennan JK, Ifthikharuddin JJ, Nichols D, Liesveld JL
    Blood Cells Mol Dis 2002 May-Jun;28(3):315-21
  • Optimal Cytokine Stimulation for the Enhanced Generation of Leukemic Dendritic Cells in Short-Term Culture
    Panoskaltsis N, Belanger TJ, Liesveld JL, Abboud CN
    Leuk Res 2002 Feb;26(2):191-201
  • Response of Human CD34+ Cells to CXC, CC, and CX3C Chemokines: Implications for Cell Migration and Activation
    Liesveld JL, Rosell K, Panoskaltsis N, Belanger T, Harbol A, Abboud CN
    J Hematother Stem Cell Res 2001 Oct;10(5):643-55
  • Flavopiridol Induces Apoptosis and Caspase-3 Activation of a Newly Characterized Burkitt's Lymphoma Cell Line Containing Mutant p53 Genes
    Rapoport AP, Simons-Evelyn M, Chen T, Sidell R, Luhowskyj S, Rosell K, Obrig T, Hicks D, Hinkle PM, Nahm M, Insel RA, Abboud CN
    Blood Cells Mol Dis 2001 May-Jun;27(3):610-24
  • MIP-1alpha and TGF-Beta Production in CD34+ Progenitor-Stromal Cell Coculture Systems: Effects of Progenitor Isolation Method and Cell-Cell Contact
    Liesveld JL, Harbol AW, Belanger T, Rosell KE, Abboud CN
    Blood Cells Mol Dis 2000 Aug;26(4):261-75
  • Outcomes of High-Dose Chemotherapy and Autologous Stem Cell Transplant in Isolated Locally Recurrent Breast Cancer: A Multicenter Evaluation
    Vij R, DiPersio J, Brown R, Trinkaus K, Abboud C, Meehan KR, Frenette G, Freytes C, Goodnough LT, Khoury H, Ponnuri J, Adkins D
    Bone Marrow Transplant 2000 Nov;26(9):947-53
  • Mobilization of Peripheral-Blood Stem Cells by Concurrent Administration of Daniplestim and Granulocyte Colony-Stimulating Factor in Patients With Breast Cancer or Lymphoma
    DiPersio JF, Schuster MW, Abboud CN, Winter JN, Santos VR, Collins DM, Sherman JW, Baum CM
    J Clin Oncol 2000 Jul;18(14):2762-71
  • Allogeneic Bone Marrow Transplantation for Children With Acute Leukemia: Cytoreduction With Fractionated Total Body Irradiation, High-Dose Etoposide and Cyclophosphamide
    Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF
    Bone Marrow Transplant 2000 Mar;25(5):489-94
  • Treatment of Chronic Myelogenous Leukemia With Autologous Bone Marrow Transplantation Followed by Roquinimex
    Rowe JM, Rapoport AP, Ryan DH, Nilsson BI, Duerst RE, Packman CH, Abboud CN, DiPersio JF, Linder T, Wang N, Simonsson B, Liesveld JL
    Bone Marrow Transplant 1999 Nov;24(10):1057-63
  • Analysis of Factors That Correlate With Mucositis in Recipients of Autologous and Allogeneic Stem-Cell Transplants
    Rapoport AP, Miller Watelet LF, Linder T, Eberly S, Raubertas RF, Lipp J, Duerst R, Abboud CN, Constine L, Andrews J, Etter MA, Spear L, Powley E, Packman CH, Rowe JM, Schwertschlag U, Bedrosian C, Liesveld JL
    J Clin Oncol 1999 Aug;17(8):2446-53
  • Continuous Infusion Cyclosporine and Nifedipine to Day +100 With Short Methotrexate and Steroids as GVHD Prophylaxis in Unrelated Donor Transplants
    Liesveld J, Duerst R, Rapoport A, Constine L, Abboud C, Packman C, Wedow L, Zwetsch L, McKenna B, Linder T, Silverman W, Swift S, Rowe J, DiPersio J
    Bone Marrow Transplant 1999 Sep;24(5):511-6
  • Effect of Nitric Oxide Production and Oxygen Tension on Progenitor Preservation in Ex Vivo Culture
    Reykdal S, Abboud C, Liesveld J
    Exp Hematol 1999 Mar;27(3):441-50
  • A RANTES-Antibody Fusion Protein Retains Antigen Specificity and Chemokine Function
    Challita-Eid PM, Abboud CN, Morrison SL, Penichet ML, Rosell KE, Poles T, Hilchey SP, Planelles V, Rosenblatt JD
    J Immunol 1998 Oct 1;161(7):3729-36
  • Autotransplantation for Relapsed or Refractory Hodgkin's Disease: Long-Term Follow-Up and Analysis of Prognostic Factors
    Lancet JE, Rapoport AP, Brasacchio R, Eberly S, Raubertas RF, Linder T, Muhs A, Duerst RE, Abboud CN, Packman CH, DiPersio JF, Constine LS, Rowe JM, Liesveld JL
    Bone Marrow Transplant 1998 Aug;22(3):265-71
  • Effect of Stromal Cell Coculture on Progenitor Cell Expansion and Myeloid Effector Function in Vitro
    Liesveld JL, Martin BA, Harbol AW, Rosell KE, Belanger TJ, Reykdal SE, Plekavich DL, Abboud CN
    J Hematother 1998 Apr;7(2):127-39
  • TGF-Beta Down-Regulates Stromal IL-7 Secretion and Inhibits Proliferation of Human B Cell Precursors
    Tang J, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN, Ryan DH
    J Immunol 1997 Jul 1;159(1):117-25
  • Successful Treatment of a Generalized Human Papillomavirus Infection With Granulocyte-Macrophage Colony-Stimulating Factor and Interferon Gamma Immunotherapy in a Patient With a Primary Immunodeficiency and Cyclic Neutropenia
    Gaspari AA, Zalka AD, Payne D, Menegus M, Bunce LA, Abboud CN, Tyring SK
    Arch Dermatol 1997 Apr;133(4):491-6
  • Autotransplantation for Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL): Long-Term Follow-Up and Analysis of Prognostic Factors
    Rapoport AP, Lifton R, Constine LS, Duerst RE, Abboud CN, Liesveld JL, Packman CH, Eberly S, Raubertas RF, Martin BA, Flesher WR, Kouides PA, DiPersio JF, Rowe JM
    Bone Marrow Transplant 1997 May;19(9):883-90
  • Expression of Interleukin-7 Receptor by Lineage-Negative Human Bone Marrow Progenitors With Enhanced Lymphoid Proliferative Potential and B-Lineage Differentiation Capacity
    Ryan DH, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN, Insel RA
    Blood 1997 Feb 1;89(3):929-40
  • Expression of Costimulatory Molecules: B7 and ICAM Up-Regulation After Treatment With a Suicide Gene
    Ramesh R, Munshi A, Abboud CN, Marrogi AJ, Freeman SM
    Cancer Gene Ther 1996 Nov-Dec;3(6):373-84
  • Flutamide-Induced Cyanosis Refractory to Methylene Blue Therapy
    Kouides PA, Abboud CN, Fairbanks VF
    Br J Haematol 1996 Jul;94(1):73-5
  • Stem Cell Factor and Stromal Cell Co-Culture Prevent Apoptosis in a Subculture of the Megakaryoblastic Cell Line, UT-7
    Liesveld JL, Harbol AW, Abboud CN
    Leuk Res 1996 Jul;20(7):591-600
  • In Vivo Analysis of the 'Bystander Effect': A Cytokine Cascade
    Ramesh R, Marrogi AJ, Munshi A, Abboud CN, Freeman SM
    Exp Hematol 1996 Jun;24(7):829-38
  • Patients > or = Age 40 Years Undergoing Autologous or Allogeneic BMT Have Regimen-Related Mortality Rates and Event-Free Survivals Comparable to Patients < Age 40 Years
    Rapoport AP, DiPersio JF, Martin BA, Duerst RE, Kouides PA, Liesveld JL, Abboud CN, Packman CH, Eberly SW, Sherman M, et al.
    Bone Marrow Transplant 1995 Apr;15(4):523-30
  • The Treatment of Ovarian Cancer With a Gene Modified Cancer Vaccine: A Phase I Study
    Freeman SM, McCune C, Robinson W, Abboud CN, Abraham GN, Angel C, Marrogi A
    Hum Gene Ther 1995 Jul;6(7):927-39
  • Effect of Stem Cell Factor on Myelopoiesis Potential in Human Dexter-Type Culture Systems
    Liesveld JL, Broudy VC, Harbol AW, Abboud CN
    Exp Hematol 1995 Mar;23(3):202-9
  • Gene-Modified Cells for the Treatment of Cancer
    Whartenby KA, Abraham GN, Calabresi PA, Abboud CN, Calabresi P, Marrogi A, Freeman SM
    Pharmacol Ther 1995 Apr;66(1):175-90
  • Enhanced Tumor Recognition and Killing Using the HSV-TK Suicide Gene
    Freeman SM, Ramesh R, Munshi A, Abboud CN, Marrogi AJ
    Cancer Gene Ther 1995;2:240-241
  • Characterization of the Adherence of Normal and Leukemic CD34+ Cells to Endothelial Monolayers
    Liesveld JL, Frediani KE, Harbol AW, DiPersio JF, Abboud CN
    Leukemia 1994 Dec;8(12):2111-7
  • CD34+ Progenitor Cell Isolation From Blood and Marrow: A Comparison of Techniques for Small-Scale Selection
    Winslow JM, Liesveld JL, Ryan DH, DiPersio JF, Abboud CN
    Bone Marrow Transplant 1994 Aug;14(2):265-71
  • Effects of GM-CSF on Ki67 Expression and Cell Cycle Traverse in Acute Myelogenous Leukemia Specimens and Cell Lines
    Liesveld JL, Keng PC, Rowe JM, DiPersio JF, Abboud CN
    Leuk Res 1994 Aug;18(8):609-16
  • Stem Cell Factor Regulates Human Melanocyte-Matrix Interactions
    Scott G, Ewing J, Ryan D, Abboud C
    Pigment Cell Res 1994 Feb;7(1):44-51
  • Cytokine Regulation of Early Human Lymphopoiesis
    Ryan DH, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN
    J Immunol 1994 Jun 1;152(11):5250-8
  • One Hundred Autotransplants for Relapsed or Refractory Hodgkin's Disease and Lymphoma: Value of Pretransplant Disease Status for Predicting Outcome
    Rapoport AP, Rowe JM, Kouides PA, Duerst RA, Abboud CN, Liesveld JL, Packman CH, Eberly S, Sherman M, Tanner MA, et al.
    J Clin Oncol 1993 Dec;11(12):2351-61
  • The "Bystander Effect": Tumor Regression When a Fraction of the Tumor Mass Is Genetically Modified
    Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN
    Cancer Res 1993 Nov 1;53(21):5274-83
  • Signal Pathway Regulation of Interleukin-8-Induced Actin Polymerization in Neutrophils
    Sham RL, Phatak PD, Ihne TP, Abboud CN, Packman CH
    Blood 1993 Oct 15;82(8):2546-51
  • Phenotypic Characterization of the Human Fibrous Histiocytoma Giant Cell Tumor (GCT) Cell Line and Its Cytokine Repertoire
    Liesveld JL, Rush S, Kempski MC, Turner AR, Brennan JK, Gasson JC, Abboud CN
    Exp Hematol 1993 Sep;21(10):1342-52
  • Expression of Integrins and Examination of Their Adhesive Function in Normal and Leukemic Hematopoietic Cells
    Liesveld JL, Winslow JM, Frediani KE, Ryan DH, Abboud CN
    Blood 1993 Jan 1;81(1):112-21
  • In Vitro Erythroid Effects of Human Stem Cell Factor in a Case of Human Immunodeficiency Virus-Related Chronic Parvovirus B19 Induced Anemia
    Liesveld JL, Weissbach NE, Shafer JA, Abboud CN
    Hematol Pathol 1993;7(1):23-32
  • Treatment of Ovarian Cancer Using HSV-TK Gene-Modified Vaccine - Regulatory Issues
    Freeman SM, McCune C, Angel C, Abraham GN, Abboud CN
    Human Gene Ther 1992;3:342-349
  • Inhibition of Human Bone Marrow Lymphoid Progenitor Colonies by Antibodies to VLA Integrins
    Ryan DH, Nuccie BL, Abboud CN
    J Immunol 1992 Dec 1;149(11):3759-64
  • Characterization of the Human Mesenchymal GCT Cell Line: A Model for Stromal Hematopoietic Cell Interactions
    Abboud CN, Rush S, Landesberg RL, Gasson JC, Liesveld JL
    In: Molecular Biology of Hematopoiesis, Volume 2 (Abraham NG, Konwalinka G, Marks P, Sachs L, Tavassoli M, eds), Intercept Ltd, Andover, UK, pp 321-334, 1992
  • Diethyldithiocarbamate Induction of Cytokine Release in Human Long-Term Bone Marrow Cultures
    East CJ, Abboud CN, Borch RF
    Blood 1992 Sep 1;80(5):1172-7
  • Vascular Cell Adhesion Molecule-1 and the Integrin VLA-4 Mediate Adhesion of Human B Cell Precursors to Cultured Bone Marrow Adherent Cells
    Ryan DH, Nuccie BL, Abboud CN, Winslow JM
    J Clin Invest 1991 Sep;88(3):995-1004
  • Cytokine Effects and Role of Adhesive Proteins and Fc Receptors in Human Macrophage-Mediated Antibody Dependent Cellular Cytotoxicity
    Liesveld JL, Frediani KE, Winslow JM, Duerst RE, Abboud CN
    J Cell Biochem 1991 Apr;45(4):381-90
  • Macrophage-Active Colony-Stimulating Factors Enhance Human Immunodeficiency Virus Type 1 Infection in Bone Marrow Stem Cells
    Kitano K, Abboud CN, Ryan DH, Quan SG, Baldwin GC, Golde DW
    Blood 1991 Apr 15;77(8):1699-705
  • Signal Transduction and the Regulation of Actin Conformation During Myeloid Maturation: Studies in HL60 Cells
    Sham RL, Packman CH, Abboud CN, Lichtman MA
    Blood 1991 Jan 15;77(2):363-70
  • Adhesive Interactions of Normal and Leukemic Human CD34+ Myeloid Progenitors: Role of Marrow Stromal, Fibroblast, and Cytomatrix Components
    Liesveld JL, Winslow JM, Kempski MC, Ryan DH, Brennan JK, Abboud CN
    Exp Hematol 1991 Jan;19(1):63-70
  • Control of Actin Conformation in AML Myeloblasts: The Effects of Bryostatin and TPA
    Sham RL, Packman CH, Abboud CN, Lichtman MA
    Leuk Res 1990;14(10):863-8
  • Maturation-Dependent Adhesion of Human B Cell Precursors to the Bone Marrow Microenvironment
    Ryan DH, Nuccie BL, Abboud CN, Liesveld JL
    J Immunol 1990 Jul 15;145(2):477-84
  • Examination of Survival, Proliferation and Cell Surface Antigen Expression of Human Monocytes Exposed to Macrophage Colony-Stimulating Factor (M-CSF)
    Erickson-Miller CL, Brennan JK, Abboud CN
    Int J Cell Cloning 1990 Sep;8(5):346-56
  • Quantitation of the Binding of Human CD34 Positive Myeloid Progenitors to Marrow Stroma Fibroblasts, and Components of the Extracellular Matrix
    Liesveld JL, Ryan DH, Kempski, MC, Brennan JK, Abboud CN
    In: Hematopoiesis, UCLA Symposium on Molecular and Cellular Biology (Clark SC, Golde DW, eds), Wiley-Liss (John Wiley & Sons, Inc), New York, pp 157-169, 1990
  • An 80,000-Kd Glycoprotein Cell Surface Antigen Found Only on Nonhematopoietic Cells in Human Bone Marrow
    Iyer J, Duerst RE, Looney JN, Humphries RK, Abboud CN, Frantz CN
    Exp Hematol 1990 Jun;18(5):384-9
  • Characterization of Human Marrow Stromal Cells: Role in Progenitor Cell Binding and Granulopoiesis
    Liesveld JL, Abboud CN, Duerst RE, Ryan DH, Brennan JK, Lichtman MA
    Blood 1989 May 15;73(7):1794-800
  • Effect of Hydrocortisone and Interleukins 1 and 2 on Eosinophil Progenitors in Hypereosinophilic States
    Liesveld JL, Abboud CN, Slovick FT, Rowe JM, Brennan JK
    Int J Cell Cloning 1988 Nov;6(6):404-16
  • Expression of IgG Fc Receptors in Myeloid Leukemic Cell Lines. Effect of Colony-Stimulating Factors and Cytokines
    Liesveld JL, Abboud CN, Looney RJ, Ryan DH, Brennan JK
    J Immunol 1988 Mar 1;140(5):1527-33
  • Purification of GCT Cell-Derived Human Colony-Stimulating Factors
    Erickson-Miller CL, Abboud CN, Brennan JK
    Exp Hematol 1988 Mar;16(3):184-9
  • Macrophage Colony-Stimulating Factor in Nerve Growth Factor Preparations
    Erickson-Miller CL, Abboud CN, Stach RW, Frantz CN, Brennan JK
    J Neurosci Res 1988;19(1):52-6
  • Interactions of Dimethyl Sulfoxide and Granulocyte-Macrophage Colony-Stimulating Factors on the Growth and Maturation of HL-60 Cells
    Brennan JK, Lee KS, Abboud CN, Erickson-Miller CL, Keng PC
    J Cell Physiol 1987 Aug;132(2):246-54
  • Lysis of Human Fibroblast Colony-Forming Cells and Endothelial Cells by Monoclonal Antibody (6-19) and Complement
    Abboud CN, Duerst RE, Frantz CN, Ryan DH, Liesveld JL, Brennan JK
    Blood 1986 Dec;68(6):1196-200
  • Modulation of in Vitro Eosinophil Progenitors by Hydrocortisone: Role of Accessory Cells and Interleukins
    Slovick FT, Abboud CN, Brennan JK, Lichtman MA
    Blood 1985 Nov;66(5):1072-9
  • The Requirements for Ionized Calcium and Magnesium in Lymphocyte Proliferation
    Abboud CN, Scully SP, Lichtman AH, Brennan JK, Segel GB
    J Cell Physiol 1985 Jan;122(1):64-72
  • Survival of Granulocytic Progenitors in the Nonadherent and Adherent Compartments of Human Long-Term Marrow Cultures
    Slovick FT, Abboud CN, Brennan JK, Lichtman MA
    Exp Hematol 1984 Jun;12(5):327-38
  • Development of Calcium and Secretory Responses in the Human Promyelocytic Leukemia Cell Line HL60
    Naccache PH, Molski TF, Spinelli B, Borgeat P, Abboud CN
    J Cell Physiol 1984 May;119(2):241-6
  • Hierarchy of Granulocytic Progenitor Cells in Human Long Term Marrow Cultures
    Slovick FT, Abboud CN, Brennan JK, Lichtman MA
    In: Normal and Neoplastic Hematopoiesis (Golde DW, Marks P, eds), Alan R Liss, New York, pp 389-398, 1983
  • The Effect of Steroids and Filtration Leukapheresis on Circulating Hematopoietic Progenitor Cells
    Heal JM, Abboud CN, Brightman A, Rubery P, Brennan JK, Nusbacher J
    Int J Cell Cloning 1983 Dec;1(6):464-77
  • Secretion of Plasminogen Activator by the Human Macrophage-Like Cell Line, GCT: Separation From Colony-Stimulating and Erythropoiesis-Enhancing Activities
    Barlow GH, Brennan JK, Abboud CN, Francis CW, Lichtman AH, Lichtman MA
    Br J Haematol 1982 Dec;52(4):645-55
  • Hydrophobic Adsorption Chromatography of Colony-Stimulating Activities and Erythroid-Enhancing Activity From the Human Monocyte-Like Cell Line, GCT
    Abboud CN, Brennan JK, Barlow GH, Lichtman MA
    Blood 1981 Dec;58(6):1148-54
  • Autostimulation of Growth by Human Myelogenous Leukemia Cells (HL-60)
    Brennan JK, Abboud CN, DiPersio JF, Barlow GH, Lichtman MA
    Blood 1981 Oct;58(4):803-12
  • Erythropoietic Enhancing Activity (EEA) Secreted by the Human Cell Line, GCT
    Abboud CN, DiPersio JF, Brennan JK, Lichtman MA
    J Supramol Struct 1980;13(2):199-209
  • The Fractionation, Characterization, and Subcellular Localization of Colony-Stimulating Activities Released by the Human Monocyte-Like Cell Line, GCT
    DiPersio JF, Brennan JK, Lichtman MA, Abboud CN, Kirkpatrick FH
    Blood 1980 Oct;56(4):717-27
  • Quantification of Erythroid and Granulocytic Precursor Cells in Plateletpheresis Residues
    Abboud CN, Brennan JK, Lichtman MA, Nusbacher J
    Transfusion 1980 Jan-Feb;20(1):9-16
  • The Exceptional Responsiveness of Certain Human Myeloid Leukemia Cells to Colony-Stimulating Activity
    Brennan JK, DiPersio JF, Abboud CN, Lichtman MA
    Blood 1979 Dec;54(6):1230-9